|
Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 933,10 INR | -2,99% |
|
-3,76% | +3,35% |
| 18/07 | Natco Pharma Limited reçoit une approbation provisoire de la FDA pour ses comprimés d'Olaparib | CI |
| 14/07 | NATCO Pharma acquiert une participation supplémentaire de 13 % dans Adcock Ingram | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2,99% | -3,76% | +5,54% | -12,86% | +3,35% | -8,02% | +21,25% | -14,57% | +56,16% | 1,79 Md | |
| +2,49% | +1,98% | +6,99% | +30,16% | +9,37% | +54,22% | +154,40% | +395,35% | +1 361,95% | 1 048 Md | |
| +0,72% | -1,28% | +9,73% | +10,81% | +21,10% | +52,48% | +47,25% | +47,86% | +100,25% | 603 Md | |
| +1,07% | +4,62% | +18,30% | +24,85% | +12,08% | +38,54% | +78,17% | +118,91% | +300,85% | 452 Md | |
| +0,06% | +1,30% | +4,99% | +6,83% | +1,92% | +31,64% | +22,30% | -2,49% | +33,91% | 327 Md | |
| -0,07% | +2,97% | +4,44% | +8,69% | +14,62% | +36,32% | +38,35% | +49,87% | +52,54% | 283 Md | |
| +1,28% | +0,65% | -4,83% | -12,99% | -8,28% | +22,18% | +17,33% | +49,52% | +174,21% | 259 Md | |
| +0,16% | -1,94% | +8,07% | +30,18% | -0,34% | -23,53% | -41,06% | +15,66% | +72,88% | 219 Md | |
| +0,57% | +3,09% | +8,48% | +6,20% | +11,89% | +23,78% | +55,97% | +49,58% | +123,06% | 198 Md | |
| -2,20% | +0,18% | +5,27% | -2,26% | +6,14% | +20,32% | +61,56% | +90,44% | +49,34% | 162 Md | |
| +0,77% | +2,85% | -1,07% | -8,68% | +0,16% | +2,80% | -33,32% | -39,20% | -32,06% | 142 Md | |
| +1,28% | +6,99% | +12,83% | +2,59% | +12,96% | +30,50% | -5,80% | -9,28% | -19,30% | 124 Md | |
| +0,31% | +1,19% | +6,72% | +10,40% | +6,32% | +5,13% | +32,98% | +145,58% | +417,11% | 122 Md | |
| +1,00% | +1,63% | +6,91% | -4,06% | -6,31% | -6,12% | -21,06% | -11,46% | +1,17% | 105 Md | |
| +0,74% | -0,86% | -1,27% | -8,43% | +4,14% | +41,00% | +36,12% | +7,83% | -8,41% | 101 Md | |
| -1,23% | +2,50% | -2,87% | -16,60% | -11,37% | +7,74% | +79,55% | +74,95% | +462,00% | 74,7 Md | |
| -1,15% | +0,20% | +13,44% | -1,47% | -7,79% | -5,29% | +19,60% | -12,78% | +247,18% | 53,47 Md | |
| -0,05% | +4,99% | +11,60% | +4,40% | +14,83% | +30,48% | +25,92% | +50,05% | +24,54% | 54,43 Md | |
| -1,01% | -1,36% | +23,26% | +16,95% | +27,15% | +69,25% | -8,60% | -7,96% | -48,89% | 53,37 Md | |
| -0,11% | +2,42% | +10,95% | +6,36% | -1,84% | +3,63% | +9,40% | - | - | 43,44 Md | |
| Moyenne | -0,25% | +1,35% | +7,37% | +4,55% | +5,51% | +21,35% | +29,52% | +52,52% | +177,29% | 221,4 Md | |
| Moyenne pondérée par Capi. | -0,24% | +1,70% | +7,48% | +12,95% | +8,35% | +33,71% | +60,70% | +129,75% | +418,16% |
- Bourse
- Actions
- Action NATCOPHARM
- Secteur NATCO Pharma Limited
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
